Bayer Aktiengesellschaft against Eli Lilly and Company — live side-by-side technical comparison.
Prices as of 2026-09-23T15:37:33+00:00 UTC · updates daily
BAYN.DE leads 4 of the 5 windows we measure — over 1 month BAYN.DE is +1.7% and LLY -7.7%; over year to date BAYN.DE is +33.2% and LLY +7.1%.
| BAYN.DE | LLY | |
|---|---|---|
| Price | $49.31 | $1150.99 |
| 1 day | -0.5%lead | -1.6% |
| 5 days | +0.7% | +1.2%lead |
| 1 month | +1.7%lead | -7.7% |
| 6 months | +28.2%lead | +26.4% |
| Year to date | +33.2%lead | +7.1% |
| 52-week position | 84% of range | 76% of range |
| 52-week range | $25.78–$53.92 | $712.05–$1292.65 |
| vs 50-day average | above $48.45 | below $1176.62 |
| vs 200-day average | above $42.54 | above $1068.31 |
| RSI (14) | 50 | 46 |
| Next earnings | 2026-11-03 | 2026-10-29 |
BAYN.DE trades at $49.31, above its 50-day average of $48.45, and above the 200-day at $42.54. It sits at 84% of its 52-week range ($25.78–$53.92); 14-day RSI is 50, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $50.00 (1.4% away) and the first support below is $48.45 (1.7% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
LLY trades at $1,150.99, below its 50-day average of $1,176.62, and above the 200-day at $1,068.31. It sits at 76% of its 52-week range ($712.05–$1,292.65); 14-day RSI is 46, in neutral territory; an average session moves it about 2.4%. For levels, the first level overhead is $1,176.62 (2.2% away) and the first support below is $1,150.00 (0.1% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.
Both move about the same amount day to day (2.5% and 2.4% of price), so the same position size carries comparable risk in either.
The comparison turns on those levels: BAYN.DE clearing $50.00 or losing $48.45; LLY clearing $1,176.62 or losing $1,150.00. Until one of them gives way, the relative reading above stands.